Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2011 First Quarter Financial Results
SCOTTSDALE, Ariz., July 28 /PRNewswire-FirstCall/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company, announced today that financial results for the fiscal 2011 first quarter ended June 30, 2010, will be released after the market closes on Tuesday, August 3, 2010. An earnings conference call will be held the following morning on Wednesday, August 4, 2010 at 11:00 AM ET.
To access the teleconference, please call (888) 287-5536 (domestic) or (719) 325-2332 (international). To listen to the teleconference via the Internet, go to http://www.matrixxinc.com and click on Events & Presentations.
A replay of the call will be available at (888) 203-1112 (domestic) or (719) 457-0820 (international), replay code 5413220 for 3 days following the call, and the web cast will be archived on the company's website, http://www.matrixxinc.com, for 30 days.
About Matrixx Initiatives, Inc.
Matrixx Initiatives, Inc. is engaged in the development and marketing of over-the-counter healthcare products that utilize innovative drug delivery systems. Zicam, LLC, its wholly-owned subsidiary, markets and sells Zicam® products in the cough and cold category. The Company markets a full line of Zicam brand pharmaceuticals, including Zicam Cold Remedy in multiple oral delivery forms; Zicam Allergy and Congestion Relief products; as well as Zicam Cough and Zicam Multi-Symptom relief items. For more information regarding Matrixx products, go to www.Zicam.com. To find out more about Matrixx Initiatives, Inc. (Nasdaq: MTXX), visit our website at www.matrixxinc.com. For additional information, contact William Hemelt, President and Chief Executive Officer, 602-385-8888, or Bill Barba, Vice President of Finance & Accounting, 602-385-8881. Matrixx is located at 8515 E. Anderson Dr., Scottsdale, Arizona 85255.
SOURCE Matrixx Initiatives, Inc.
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.